IMC Chicago’s Novo Nordisk NVO Stock Holding History

IMC Chicago’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$76.7M	Sell	2,086,200 -302,400	-13%	-$14.3M	0.03%	363
2025 Q4	$122M	Buy	2,388,600 +354,600	+17%	+$18.1M	0.04%	256
2025 Q3	$113M	Buy	2,034,000 +922,900	+83%	+$54M	0.04%	253
2025 Q2	$76.7M	Buy	1,111,100 +229,200	+26%	+$15.6M	0.03%	286
2025 Q1	$61.2M	Sell	881,900 -413,300	-32%	-$34.1M	0.03%	269
2024 Q4	$111M	Buy	1,295,200 +779,300	+151%	+$84.3M	0.05%	188
2024 Q3	$61.4M	Buy	515,900 +68,200	+15%	+$9.1M	0.03%	262
2024 Q2	$63.9M	Sell	447,700 -41,600	-9%	-$5.51M	0.04%	242
2024 Q1	$62.8M	Buy	489,300 +277,400	+131%	+$33M	0.04%	210
2023 Q4	$21.9M	Buy	211,900 +63,300	+43%	+$6.26M	0.01%	431
2023 Q3	$13.5M	Buy	+148,600	New	+$13.1M	0.01%	473

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

IMC Chicago's NVO Position: Q1 2026 in Review

IMC Chicago increased its Novo Nordisk (NVO) stake by 648% in Q1 2026, buying an estimated $32.9M and bringing the position to 802,198 shares worth $29.5M. The position accounts for 0.01% of the portfolio, ranked #693.

IMC Chicago first reported a position in NVO in Q3 2024 and has held it in 7 quarters since. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

IMC Chicago held 802,198 shares of Novo Nordisk worth $29.5M as of Q1 2026.
IMC Chicago bought 694,983 Novo Nordisk shares in Q1 2026, an estimated $32.9M.
Novo Nordisk made up 0.01% of IMC Chicago's portfolio in Q1 2026, its #693 holding.
IMC Chicago first reported a position in Novo Nordisk in Q3 2024 and has held it in 7 quarters since.
1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.